ADAR1 Capital Management »

Ascendis Pharma A S shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.3M 49k 151.17
2023-12-31 $5.8M 46k 125.95

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
FMR
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
T. Rowe Price Investment Management
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Sofinnova Ventures
Brown Advisory Holdings Incorporated
Spyglass Capital Management
Alliancebernstein

View all funds holding Ascendis Pharma A S